Latest filing published 20 Jun 2013 for GENEREX BIOTECHNOLOGY CORP, €67k.
Insider track record
No signal scores available.
Stephen Fellows: trading record in brief
Stephen Fellows discloses dealings in Generex Biotechnology Corp to SEC (Form 4). We count 4 filings; the first trade dates from 21 June 2012 and the latest from 18 June 2013.
The open-market record consists of 2 sales worth €107k, with no purchase. Outside the open market, there are 2 option exercises. So far in 2013, the count stands at no purchases and 1 sale.
The latest filing, published on 20 June 2013, reports an open-market sale of €67k in Generex Biotechnology Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen Fellows
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,524,164 shares@ US$0.0355Common StockSEC:0001363585-13-000016:0
- 2,524,164 shares0Common StockSEC:0001363585-13-000013:0
- 546,448 shares@ US$0.0922Common StockSEC:0001363585-12-000010:0
- 546,448 shares0Common StockSEC:0001363585-12-000008:0
4 of 4 declarations